PCOS and Endometriosis Diagnosis and Treatment with Dr. Thaïs Aliabadi
Leading OB/GYN reveals why PCOS and endometriosis often go undiagnosed and shares evidence-based treatments for women's hormone health.
Summary
Dr. Thaïs Aliabadi, a leading OB/GYN, discusses two major but frequently undiagnosed women's health conditions: PCOS and endometriosis. She explains the four PCOS phenotypes, underlying insulin resistance, and evidence-based treatments including metformin, berberine, and lifestyle interventions. The conversation covers endometriosis symptoms, surgical treatments, and fertility impacts. Dr. Aliabadi also addresses breast cancer screening, hormone testing recommendations, and perimenopause management. Key takeaways include specific diagnostic tests women should request, supplement protocols for hormone balance, and early screening strategies for fertility preservation.
Detailed Summary
This comprehensive discussion with Dr. Thaïs Aliabadi addresses critical gaps in women's health education, focusing on conditions that affect millions but often go undiagnosed for years. The episode is essential listening for women seeking to optimize their reproductive and hormonal health throughout their lifespan.
The conversation extensively covers PCOS, affecting up to 20% of women, explaining four distinct phenotypes and the central role of insulin resistance and chronic inflammation. Dr. Aliabadi details evidence-based treatments including metformin, berberine supplementation, and lifestyle interventions. She emphasizes the importance of early AMH testing to assess egg reserves and provides age-specific ranges for fertility planning.
Endometriosis receives equally thorough coverage, with discussion of its inflammatory nature, impact on egg quality, and various surgical treatment approaches. Dr. Aliabadi explains why painful periods are not normal and provides specific screening questions women should ask their doctors. The conversation also addresses the complex relationship between endometriosis and fertility, including when egg freezing might be recommended.
Additional topics include breast cancer risk assessment using the Tyrer-Cuzick calculator, hormone testing protocols, fibroid management, and perimenopause symptoms like brain fog and hair loss. Dr. Aliabadi provides specific supplement recommendations including inositol for mood and metabolic support, and discusses emerging treatments like GLP-1 medications for PCOS management. The episode emphasizes patient advocacy and provides practical tools for women to take control of their health.
Key Findings
- PCOS has four distinct phenotypes requiring different treatment approaches beyond just insulin resistance
- AMH testing by age 25 helps assess egg reserves; normal ranges vary significantly by age decade
- Berberine 500mg twice daily can be as effective as metformin for PCOS insulin resistance
- Painful periods are never normal and may indicate endometriosis requiring medical evaluation
- Inositol supplementation supports both mood regulation and metabolic function in PCOS patients
- Pelvic ultrasounds can detect fibroids, ovarian cysts, and structural abnormalities affecting fertility
- Tyrer-Cuzick calculator provides personalized breast cancer risk assessment for screening decisions
- GLP-1 medications show promise for PCOS treatment beyond diabetes and weight management
Methodology
This is an interview-format podcast episode from Huberman Lab featuring Dr. Thaïs Aliabadi, a board-certified OB/GYN surgeon and women's health expert. The discussion spans over 3 hours covering clinical experience and evidence-based treatment approaches.
Study Limitations
Individual treatment approaches should be personalized with qualified healthcare providers. Supplement dosages and medication decisions require medical supervision. Some emerging treatments like GLP-1s for PCOS may need additional research for optimal protocols.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.